0910-AC10 200104 Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Overwrap for Inhalation Products Packaged in Low Density Polyethylene (LDPE) Containers The proposed rule would require overwrap on all inhalation products packaged in low density polyethylene (LDPE) containers to prevent ingress of contaminates. Substantive, Nonsignificant Previously Published in The Unified Agenda Proposed Rule Stage Undetermined Undetermined 21 CFR 200 21 USC 321 21 USC 331 21 USC 351 21 USC 352 21 USC 353 21 USC 358 21 USC 360 21 USC 371 21 USC 374 21 USC 375 No NPRM 11/00/2001 Undetermined No None NA Not Collected Carol Drew 0910 Food and Drug Administration FDA 301 796-3601 301 847-8440 Suite 3037 (HFD-7), Center for Drug Evaluation and Research, WO 51, Room 6306, 10903 New Hampshire Avenue, Silver Spring MD 20993-0002 Not Procurement Related No